| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 175,475 | 164,569 | 164,062 | 179,246 | | Cost of Revenue | 87,839 | 87,257 | 87,710 | 90,207 | | | Gross Profit | 87,636 | 77,312 | 76,352 | 89,039 | | | Operating Expenses | | Research Development | 7,705 | 7,396 | 8,489 | 7,673 | | Selling General and Administrative | 67,480 | 64,147 | 61,853 | 66,474 | | Non Recurring | 602 | 734 | (1,336) | 868 | | Others | 3,076 |
-
|
-
|
-
| | | | Total Operating Expenses | 78,863 |
-
|
-
|
-
| | | | Operating Income or Loss | 5,002 | 5,035 | 7,346 | 14,024 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,847) |
-
| 1,083 | 4,376 | | Earnings Before Interest And Taxes | 1,926 | 5,035 | 8,429 | 18,400 | | Interest Expense | (16) | 2,780 | 2,533 | 2,315 | | Income Before Tax | 1,942 | 2,255 | 5,896 | 16,085 | | Income Tax Expense | 654 | 846 | 1,411 | 5,508 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,371 | 1,409 | 4,485 | 10,577 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,288 | 1,409 | 4,485 | 10,577 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,288 | $1,409 | $4,485 | $10,577 |
|
0.51% Nasdaq 
Income Statement
